Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Modernization is not optional anymore. It’s literally the question of your business survival. Usage of obsolete systems is ...

7 newer data science tools you should be using with Python Already using NumPy, Pandas, and Scikit-learn? Here are seven more powerful data wrangling tools that deserve a place in your toolkit. The ...